Dosage of Propofol Based on Lean Body Weight

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-15

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients who will be anesthesia induced with propofol will be body analyzed with Tanita before the operation. Height, weight, age, gender and other general information of the patients will be recorded. Total body weight (TBW), ideal body weight (IBW) and lean body weight (LBW) will be calculated. Patients over 18 years of age who will be operated under general anesthesia for 2-6 hours will be included. Patients allergic to propofol or contraindicated to propofol will be excluded. In the study, in order to decide and test the most appropriate weight-based scale for the evaluation of propofol dosage for induction of anesthesia by identifying patients who need additional propofol during intubation, Ingrande et al. After monitoring, propofol infusion (100 mg/kg/hour) will be started according to total body weight and the infusion will be stopped when the BIS value is between 50 and 40 and the elapsed time will be recorded. Routine anesthesia applications will be performed by applying neuromuscular blocker. Total Propofol dose administered will be calculated according to the dose TBW, IBW and LBW in kilograms. The relationship between the doses administered and body mass index will be evaluated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Lean Body Weight-adjusted Rocuronium Dose and Intubation Conditions

NCT05476952

Body Weight Changes Rocuronium Intubation Conditions

COMPLETED

The Role of Anthropometric Measurements and Ultrasonograpic Suprasternal Adipose Tissue Thickness

NCT06457165

Intubation; Difficult or Failed Obesity Anesthesia

COMPLETED

The Relationship Between Body Mass Index and Patient Outcomes in Low Flow Anaesthesia

NCT06636448

Major Gynecological Cancer Surgery Low Flow Anesthesia

COMPLETED

Comparison of Low Versus Normal Flow Anesthesia on Cerebral Oxygenation and Bispectral Index in Morbidly Obese Patients

NCT03438734

Morbid Obesity Anesthesia Awareness Anesthesia Complication

COMPLETED NA

PERFUSION INDEX, PRONE ,SUPİNE AND SITTING POSITION

NCT06742619

Perfusion Index

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who will be anesthesia induced with propofol will be body analyzed with Tanita before the operation. Height, weight, age, gender and other general information of the patients will be recorded. Total body weight (TBW), ideal body weight (IBW) and lean body weight (LBW) will be calculated. Patients over 18 years of age who will be operated under general anesthesia for 2-6 hours will be included. Patients who are allergic to propofol or for whom propofol is contraindicated will not be included in the study. In the study, 80 patients with a mean body mass index \[BMI\] between 18-35 and Bispectoral index (BIS) (Ingrande et al. ) monitoring, propofol infusion (100 mg/kg/hour) will be started according to total body weight, and when the BIS value is between 50 and 40, the infusion will be stopped and the elapsed time will be recorded in order to decide and test the most appropriate weight-based scale for propofol dosing for anesthesia induction to identify and evaluate patients who need additional propofol during intubation. Routine anesthesia will be performed by applying neuromuscular blocker. Total Propofol dose administered will be calculated according to TBW, IBW and LBW per kilogram. And the relationship between the doses given and body mass index will be evaluated. In our study, we aimed to evaluate the effects of Propofol dose according to lean body weight by evaluating patients with a body mass index below 35.Patients who will undergo anesthesia induction with Propofol will undergo preoperative body analysis with Tanita. Height, weight, age, gender and other general information of the patients will be recorded. Total body weight (TBW), ideal body weight (IBW) and lean body weight (LBW) will be calculated. Patients over 18 years of age who will be operated under general anesthesia for 2-6 hours will be included. Patients who are allergic to propofol or for whom propofol is contraindicated will not be included in the study. In the study, 80 patients with a mean body mass index \[BMI\] between 18-35 and Bispectoral index (BIS) (Ingrande et al. ) monitoring, propofol infusion (100 mg/kg/hour) will be started according to total body weight, and when the BIS value is between 50 and 40, the infusion will be stopped and the elapsed time will be recorded in order to decide and test the most appropriate weight-based scale for propofol dosing for anesthesia induction to identify and evaluate patients who need additional propofol during intubation. Routine anesthesia will be performed by applying neuromuscular blocker. Total Propofol dose administered will be calculated according to TBW, IBW and LBW per kilogram. And the relationship between the doses given and body mass index will be evaluated. In our study, we aimed to evaluate the effects of Propofol dose according to lean body weight by evaluating patients with a body mass index below 35.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gender Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

grup 1.Optimum range

Group 1 BMI = 18.5-24.9,

It is an observational study and no non-routine procedures will be performed on patients. Routine anesthesia procedure will be applied to the patients

Intervention Type OTHER

It is an observational study and no non-routine procedures will be performed on patients.

Routine anesthesia procedure will be applied to the patients

Group 2.Overweight

BMI = 25-29.9,

It is an observational study and no non-routine procedures will be performed on patients. Routine anesthesia procedure will be applied to the patients

Intervention Type OTHER

It is an observational study and no non-routine procedures will be performed on patients.

Routine anesthesia procedure will be applied to the patients

Group 3.Class I obesity

BMI=30-34.9

It is an observational study and no non-routine procedures will be performed on patients. Routine anesthesia procedure will be applied to the patients

Intervention Type OTHER

It is an observational study and no non-routine procedures will be performed on patients.

Routine anesthesia procedure will be applied to the patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

It is an observational study and no non-routine procedures will be performed on patients. Routine anesthesia procedure will be applied to the patients

It is an observational study and no non-routine procedures will be performed on patients.

Routine anesthesia procedure will be applied to the patients

Intervention Type OTHER